Establishing a New Standard
Aquablation therapy removes tissue effectively, consistently, and with a low risk of complications – providing the surgeon with predictable and reproducible outcomes and a better quality of life for the patient.
Predictable Precision
The world’s first autonomous tissue removal robot for the treatment of lower urinary tract symptoms due to BPH, offering the peace of mind that comes with consistency and precision.
Predictable Precision
The world’s first autonomous tissue removal robot for the treatment of lower urinary tract symptoms due to BPH, offering the peace of mind that comes with consistency and precision.
Predictable Precision
The world’s first autonomous tissue removal robot for the surgical treatment of lower urinary tract symptoms due to BPH, offering the peace of mind that comes with consistency and precision.
Better Science, Proven Data
Doubling down on scientific rigor, PROCEPT BioRobotics’ powerful WATER Study was randomized against the surgical gold-standard TURP.
Better Science, Proven Data
Doubling down on scientific rigor, PROCEPT BioRobotics’ powerful WATER Study was randomized against the surgical gold-standard TURP.
Better Science, Proven Data
Doubling down on scientific rigor, PROCEPT BioRobotics’ powerful WATER Study was randomized against the surgical gold-standard TURP.
Discover our most recent achievements, where to find us, and what industry publications have to say about us.
Press Releases
- October 1, 2018 PROCEPT BioRobotics’ Aquablation Therapy Expands Global Market Access with NICE Guidance and NTAP Incremental Payment
- May 21, 2018 PROCEPT BioRobotics’ Aquablation Meets Primary Endpoints in WATER II Study of 80 to 150 Milliliter Prostates
- March 13, 2019 Six-Month Data Highlight Safety and Efficacy of PROCEPT BioRobotics’ Aquablation® Therapy as an Effective Minimally Invasive Surgical Treatment for BPH in Prostates Up to 150 mL
Events
Discover our most recent achievements, where to find us, and what industry publications have to say about us.
Press Releases
- October 1, 2018 PROCEPT BioRobotics’ Aquablation Therapy Expands Global Market Access with NICE Guidance and NTAP Incremental Payment
- May 21, 2018 PROCEPT BioRobotics’ Aquablation Meets Primary Endpoints in WATER II Study of 80 to 150 Milliliter Prostates
- March 13, 2019 Six-Month Data Highlight Safety and Efficacy of PROCEPT BioRobotics’ Aquablation® Therapy as an Effective Minimally Invasive Surgical Treatment for BPH in Prostates Up to 150 mL
Events
BPH Education Center
What is BPH?
